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Ionizing Radiation and Cancer Prevention
David G. Hoel
Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina
Ionizing radiation long has been recognized as a cause of cancer. Among environmental cancer risks, radiation is unique in the variety of organs and
tissues that it can affect. Numerous epidemiological studies with good dosimetry provide the basis for cancer risk estimation, including quantitative
information derived from observed dose-response relationships. The amount of cancer attributable to ionizing radiation is difficult to estimate, but
numbers such as 1 to 3% have been suggested. Some radiation-induced cancers attributable to naturally occurring exposures, such as cosmic and
terrestrial radiation, are not preventable. The major natural radiation exposure, radon, can often be reduced, especially in the home, but not entirely
eliminated. Medical use of radiation constitutes the other main category of exposure; because of the importance of its benefits to one's health, the
appropriate prevention strategy is to simply work to minimize exposures. - Environ Health Perspect 103(Suppl 8):241-243 (1995)
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Introduction
It is well recognized that exposure to ioniz-
ing radiation is unavoidable. Most human
exposure is from natural sources, with
radon accounting for more than half the
total. Figure 1 illustrates the distribution of
exposure sources for the general public as
determined by the National Academy of
Science's Committee on the Biological
Effects of Ionizing Radiation (BEIR V).
The total comes to the equivalent ofabout
3.5 mSv per year per individual. With
environmental radon and man-made radia-
tion sources collectively accounting for
about three-quarters ofthe total, there is an
opportunity to reduce exposures to man.
Methods are well known for both the
assessment and the reduction of radon
exposures in the home and workplace. The
broad categories of man-made radiation
sources are provided in Figure 2. The pub-
lic's concern is focused primarily on the
smallest exposure category, occupational
and other sources, which amounts to or
represents less than 1% of total human
exposure. Although much remains to be
done in estimating health effects ofindoor
radon exposure, there has been little public
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Figure 1. Average annual radiation exposure; effective
dose equivalent in mSv.
concern over this most prominent source of
exposure. This may not appear to be ration-
al at first appearance. It makes sense, how-
ever, ifone considers that exposures received
occupationally, from toxicwaste, or through
accidents, are likely to be higher than those
from natural background radiation.
The estimate of 3% of total radiation
exposures from consumer products is some-
what misleading, since the main sources are
building materials, water supplies, and agri-
cultural products, which are not generally
thought ofas consumer products. The best-
known consumer product involving radia-
tion exposure is cigarette smoking.
Polonium 210 found in tobacco is a result
ofairborne radon decay that is deposited on
tobacco plants' leaves. Wide differences in
estimates ofradiation doses resulting from
cigarette smoking leave the contribution of
cigarette smoke to radiation carcinogenesis
somewhat uncertain (1,2).
The issue of exposures from nuclear
power and nuclear waste receives the
greatest public attention, yet these types of
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Figure 2. Average annual radiation exposure, man-
made exposures in mSv.
exposures are only a minor source of total
radiation exposure. For those close to these
sources, however, the issue is a real one.
The concern here is the risk of unforeseen
accidents as well as the public's lack of
understanding about the exposures and
their associated risks. The greatest changes
expected in the years ahead involve the
establishment of central radioactive stor-
age facilities and the massive cleanup
faced by the Department of Energy at
their many waste sites. Risks to popula-
tions in the vicinity of these activities,
including interstate transportation, need
careful assessment. Even more dangerous
is the potential health risk to the workers
engaged in the cleanup process. The
amounts and types ofradioactive materials
that will be disturbed during any such
cleanup is not completely understood.
Further, there are gaps in the knowledge of
biological effects of certain of the various
radionuclides present in waste. Unfortu-
nately, there is little interest in studying the
biological effects of the various types of
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Table 1. Major epidemiologic studies conducted to obtain estimates of radiation-induced cancer risk.
High-dose radiation studies, Nuclearworkerstudies,
number ofcancercases Low-dose radiation studies numberofdeaths
* Atomic bomb survivors, 6000 * Diagnostic radiography * British Nuclear Fuels, 2300
* Ankylosing spondylitis patients, 600 * Fallout downwind, weapons tests * U.K. Atomic EnergyAuthority, 3400
* Cervical cancer patients, 4200 (U.S., U.K., Canada), global * U.S. DOE: Hanford, Oak Ridge, Rocky
* Canadian Fluoroscopy Study, 500 breast * Near nuclear installations Flats, 7000, 1800, 400
* Postpartum Mastitis Study, 115 breast * Nuclearworkers * Atomic Energyof Canada, 900
* Tinea Capitis, 55thyroid * High natural background * Ontario Hydro, 2900
radioisotopes to which man would be
exposed in any cleanup process.
Radiation Health Issues
The complexity ofradiation types is gener-
ally not well appreciated. Natural radioac-
tivity is the property of some nuclides to
spontaneously emit particles or gamma
radiation. There are about 50 naturally
occurring radionuclides. Radiation typi-
cally is classified by the amount ofenergy
lost per unit of track length (i.e., linear
energy transfer [LET]). Low-LET radiation
is characteristic of electrons, X-rays, and
y-rays, in which the distance between ion-
izing events is large on the cellular nucleus
scale. High-LET radiation has ionization
events whose distances are small on the
nucleus scale; protons, neutrons, and alpha
(i.e., helium nucleus) are ofthis type.
Equal doses ofdifferent types of radia-
tion can produce different biological effects.
The term relative biological effectiveness
(RBE) is used to attempt to quantify these
potential differences. RBE is simply defined
as the ratio ofthe reference dose to the test
dose, where the doses produce the same
degree ofbiological effect. If, for example,
the RBE value is greater than 1 for a
particular radiation type, then this test radi-
ation is more effective or potent than the
reference or standard radiation, which is
generally 200-kVX-ray. RBE data forhigh-
LET radiation are often obtained for exper-
imental systems. Neutron cancer effects are
estimated to have RBE values around 20.
Because radioactive waste is a mixture of
various radionuclides, that emit various
types ofradiation at various energy levels, it
is necessary to arrive at a better understand-
ing ofthe biological effects ofthese expo-
sures. Further, pharmacokinetic effects
differ for the various radionuclides essential
to understanding the health risks ofthese
mixed exposures. Therefore, much more
research is needed to produce more accurate
risk assessments associated with toxic waste
and its cleanup.
A second quantity of considerable
importance is the dose rate effectiveness
factor (DREF). This factor measures the
difference between acute and chronic or
fractionated exposures ofthe same type of
radiation at the same total dose. Again, the
DREF is the ratio of doses that produce
the same effect. It has been observed in
some experimental cancer studies that for a
low-LET radiation (i.e., gamma), the
DREF ranges between 2 and 10. That is,
the continuous exposure is less effective
than the acute exposure by a factor of
between 2 and 10. This, ifcorrect, is good
news, since most occupational and envi-
ronmental exposures are chronic exposures.
For high LET, on the other hand, the
DREF value seems to be less than 1.
Therefore, environmental radon may be a
greater cancer risk than estimated from the
mining studies. Again this is an important
public health issue that should be studied,
both epidemiologically and experimentally.
Cancer Risks
The bases for radiation-induced cancer risk
estimates have been epidemiological studies
(Table 1). For low LET-exposures, namely
X-rays and y-rays, high-dose acute expo-
sures have been used. A-bomb survivor
studies predominate, as shown in Table 1,
column 1. These were the primary data
source for the work carried out by the
Committee for the Biological Effects of
Ionizing Radiation. Low-dose studies are
also available (Table 1, column 2) but do
not have an impact on the risk estimates
derived from the high-dose studies.
Numerous worker studies have also been
carried out (Table 1, column 3), and
recently those from Canada, the United
Kingdom, and the United States have been
jointly analyzed (3). The results from the
worker studies are essentially consistent
with those from the high-dose studies used
in BEIR V. The occupational studies pro-
vide a few hints about exposures to
radionuclides other than external expo-
sures. For example, the observation that
there was aslight and surprising increase in
prostate cancer in a United Kingdom
Atomic Energy Authority (UKAEA) study
(4) prompted a follow-up case-control
study (5). The results suggested that expo-
sures to tritium and several radioisotopes,
not external radiation, are the more likely
casual factors. However, the possibility
that heavy metals per se might be involved
could not be discounted.
The best information on cancer inci-
dence from acute external radiation is
found in the newA-bomb results published
this year (6,7). Table 2 presents the excess
absolute risk for specific types of solid
tumors, which were significantly increased
compared with controls. The tumor sites
have been ranked according to the amount
ofexcess risk. We see from the table that
the breast is the most sensitive site. Also,
nonmelanoma skin cancer has been added
to the list of radiation-induced cancers.
Table 3 gives hemato-lymphopoietic cancer
Table 2. Cancer incidence: atomic bomb survivors.a
Site EAR per 10,000 PYSv
Breast 6.7
Stomach 4.8
Respiratory 4.4
Urinary 2.1
Colon 1.8
Thyroid 1.6
Ovary 1.1
Skin 0.8
Liver 0.5
Abbreviations: EAR, excess absolute risk; PYSv, person
year Sieverts. aExcess cases per 10,000 PYSv.
Table 3. Cancer incidence: atomic bomb survivors.
Site EAR per 10,000 PYSv
Leukemia 2.7
ALL 0.6
AML 1.1
CML 0.9
ATL None
Other 0.2
Lymphoma None
Multiple myeloma None
Abbreviations: EAR, excess absolute risk; PYSv, per-
sonal year Sieverts; ALL, acute lymphocytic leukemia;
AML, acute myelogenius leukemia; CML, chronic
myelacylic leukemia; ATL, adultT-cell leukemia.
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riskvalues. For the first time, the riskvalues
for the various leukemia subtypes have been
made available. Ofparticular importance is
the fact that multiple myeloma was found
not to be related to radiation exposure.
Previous mortality studies have reported
that it is induced by radiation, but in the
incidence study the larger number ofcases
and the correction ofmisclassifications have
resulted in the conclusion that multiple
myeloma is not induced by radiation.
Conclusions
The estimated average exposure of 1.5 mSv
per year for nonradon sources contributes
about 4 to 5% of all cancer mortality
(Table 4). The estimate does not incorpo-
rate a dose-rate effect (DREF), for which
BEIRVsuggests a value of2 which reduces
the percentage to 2 or 3% of all cancer
mortality. Occasional worker studies sug-
gest a much greater risk. For example,
Wing et al. (9), based on a follow-up of
Oak Ridge workers, suggest that the radia-
tion-cancer dose response is 10 times
higher than estimates from A-bomb sur-
vivor studies which were the basis of the
BEIR V estimates. The Wing estimate then
translates to roughly 40 to 50% ofall can-
cer mortality being attributable to radia-
tion, which clearly is doubtful. The
estimated lung cancer risk from the 2 mSv
Table 4. Percentage of total cancer mortality, 1 mSv
exposure peryear.a
Male, % Female, %
Leukemia 8.9 8.6
Nonleukemia 2.3 3.2
Total 2.5 3.4
amSv, milliSievert. Data from the Committee on the
Biological Effects of Ionizing Radiation (8).
radon exposure presently depends on
mining data and awaits results ofenviron-
mental studies. Table 5 provides estimates
of cancer risk for the various categories of
man-made radiation sources that are theo-
retically preventable or at least reducible.
Also, there is the possibility of future
increases in exposures for older women
from such things as yearly mammography
exams, which would add about 0.2 mSv to
their radiation burden. However, because
postmenopausal women are at much less
risk of radiation-induced breast cancer
than premenopausal women, this expo-
sure, coupled with the potential benefit of
early detection, is not ofmajor concern at
this time.
Ofgreatest concern is protection ofthe
public and workers exposed to radiation
sources from the nuclear industry and
nuclear waste sites. This protection would
not measurably reduce national figures on
Table 5. Radiation cancer mortality risk, man-made
exposures.
Exposure, Cancer deaths,
mSv peryear %
Medical X-ray 0.39 1.2a
Nuclear medicine 0.14 0.4
Consumer products 0.10 0.3
Occupational 0.01 0.03
Other 0.01 0.03
mSv, milliSievert. Considering age, this value may be
two times too high from BEIR V(8).
radiation-induced cancers, but is, however,
essential to reduce the risk to those
individuals being so exposed.
Much is known about the cancer effects
ofacute exposures oflow-LET radiation.
The more relevant issue of chronic expo-
sures, however, requires additional studies
and research. For high-LET radiation-in
particular, alpha-the available data are
much more limited. We especially need
data on chronic radon exposures in the
low-dose region not only to better estimate
lung cancer risks but also to assess other
possible effects such as leukemia. Finally,
research is especially needed for a better
understanding of the potential cancer
effects of those radionuclides associated
with toxic waste.
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